On the other hand, the correlation of microRNA 16 and microRNA 21 expression with CD1a and CD11b was dramatically changed by 8-fold, 11-fold, and 7-fold, respectively, in COVID-19-positive AML patients. This evidence concerns the gene CD1A and acute myeloid leukemia.